Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 93

    1.

    Effectiveness of an intervention to improve the documentation required for diagnosis of metabolic syndrome in clinics serving African-American patients.

    Pan Q, Meng YX, Gibbons GH, Strayhorn G.

    Qual Prim Care. 2009;17(3):191-6.PMID: 19622269 [PubMed - indexed for MEDLINE]Related articles

    2.

    AJC editor's consensus: psoriasis and coronary artery disease.

    Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, Grundy SM, Jarratt MT, Krueger JG, Ridker PM, Stone N, Roberts WC.

    Am J Cardiol. 2008 Dec 15;102(12):1631-43. Review. No abstract available. PMID: 19064017 [PubMed - indexed for MEDLINE]Related articles

    3.

    Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002.

    Meng YX, Ford ES, Li C, Quarshie A, Al-Mahmoud AM, Giles W, Gibbons GH, Strayhorn G.

    Clin Chem. 2007 Dec;53(12):2152-9. Epub 2007 Oct 19.PMID: 17951292 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Neuregulin-1 attenuates neointimal formation following vascular injury and inhibits the proliferation of vascular smooth muscle cells.

    Clement CM, Thomas LK, Mou Y, Croslan DR, Gibbons GH, Ford BD.

    J Vasc Res. 2007;44(4):303-12. Epub 2007 Apr 16.PMID: 17438359 [PubMed - indexed for MEDLINE]Related articles

    5.

    Geography and genography: prediction of continental origin using randomly selected single nucleotide polymorphisms.

    Allocco DJ, Song Q, Gibbons GH, Ramoni MF, Kohane IS.

    BMC Genomics. 2007 Mar 10;8:68.PMID: 17349058 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Notch: a mastermind of vascular morphogenesis.

    Anderson LM, Gibbons GH.

    J Clin Invest. 2007 Feb;117(2):299-302.PMID: 17273550 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study.

    Song Q, Cole JW, O'Connell JR, Stine OC, Gallagher M, Giles WH, Mitchell BD, Wozniak MA, Stern BJ, Sorkin JD, McArdle PF, Naj AC, Xu Q, Gibbons GH, Kittner SJ.

    Hum Mol Genet. 2006 Aug 15;15(16):2468-78. Epub 2006 Jul 11.PMID: 16835261 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Generation of an adult smooth muscle cell-targeted Cre recombinase mouse model.

    Zhang J, Zhong W, Cui T, Yang M, Hu X, Xu K, Xie C, Xue C, Gibbons GH, Liu C, Li L, Chen YE.

    Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):e23-4. No abstract available. Erratum in: Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):e33. PMID: 16484601 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education.

    Igho-Pemu P, Quarshie A, Oduwole A, Lapu-Bula R, Mayberry R, Obialo C, Gibbons GH, Ofili E.

    Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-120-3.PMID: 16315390 [PubMed - indexed for MEDLINE]Related articles

    10.

    Genetic engineering of human embryonic stem cells with lentiviral vectors.

    Xiong C, Tang DQ, Xie CQ, Zhang L, Xu KF, Thompson WE, Chou W, Gibbons GH, Chang LJ, Yang LJ, Chen YE.

    Stem Cells Dev. 2005 Aug;14(4):367-77.PMID: 16137225 [PubMed - indexed for MEDLINE]Related articles

    11.

    Genetic markers: progress and potential for cardiovascular disease.

    Gibbons GH, Liew CC, Goodarzi MO, Rotter JI, Hsueh WA, Siragy HM, Pratt R, Dzau VJ.

    Circulation. 2004 Jun 29;109(25 Suppl 1):IV47-58. Review. No abstract available. PMID: 15226250 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Physiology, genetics, and cardiovascular disease: focus on African Americans.

    Gibbons GH.

    J Clin Hypertens (Greenwich). 2004 Apr;6(4 Suppl 1):11-8. Review.PMID: 15073462 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.

    Tomita N, Kim JY, Gibbons GH, Zhang L, Kaneda Y, Stahl RA, Ogborn M, Venderville B, Morishita R, Baran D, Dzau VJ.

    Int J Mol Med. 2004 May;13(5):629-36.PMID: 15067361 [PubMed - indexed for MEDLINE]Related articles

    14.

    Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks.

    Davis SK, Liu Y, Gibbons GH.

    Am J Public Health. 2003 Mar;93(3):447-55. Erratum in: Am J Public Health. 2003 May;93(5):703. PMID: 12604494 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: potential mediators of vascular disease.

    Campos AH, Zhao Y, Pollman MJ, Gibbons GH.

    Circ Res. 2003 Jan 10;92(1):111-8.PMID: 12522128 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation.

    Campos AH, Wang W, Pollman MJ, Gibbons GH.

    Circ Res. 2002 Nov 29;91(11):999-1006.PMID: 12456485 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Apolipoprotein E-deficient mice created by systemic administration of antisense oligodeoxynucleotides: a new model for lipoprotein metabolism studies.

    Morishita R, Gibbons GH, Kaneda Y, Zhang L, Ogihara T, Dzau VJ.

    J Endocrinol. 2002 Nov;175(2):475-85.PMID: 12429045 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells.

    Hall JL, Gibbons GH, Chatham JC.

    Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E465-71.PMID: 12169439 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways.

    Hall JL, Wang X, Van Adamson, Zhao Y, Gibbons GH.

    Circ Res. 2001 Jun 22;88(12):1247-53.PMID: 11420300 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta.

    Hall JL, Chatham JC, Eldar-Finkelman H, Gibbons GH.

    Diabetes. 2001 May;50(5):1171-9.PMID: 11334423 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway.

    Hall JL, Matter CM, Wang X, Gibbons GH.

    Circ Res. 2000 Sep 29;87(7):574-80.PMID: 11009562 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.

    Tomita N, Morishita R, Tomita S, Gibbons GH, Zhang L, Horiuchi M, Kaneda Y, Higaki J, Ogihara T, Dzau VJ.

    Gene Ther. 2000 Aug;7(15):1326-32.PMID: 10918504 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of gene therapy.

    Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ.

    Biochem Biophys Res Commun. 2000 Jul 5;273(2):666-74.PMID: 10873662 [PubMed - indexed for MEDLINE]Related articles

    24.

    Death receptors, intimal disease, and gene therapy: are therapies that modify cell fate moving too Fas?

    Gibbons GH, Pollman MJ.

    Circ Res. 2000 May 26;86(10):1009-12. Review. No abstract available. PMID: 10827127 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.

    Morishita R, Gibbons GH, Tomita N, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.

    Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):915-22.PMID: 10764654 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway.

    Bai H, Pollman MJ, Inishi Y, Gibbons GH.

    Circ Res. 1999 Aug 6;85(3):229-37.PMID: 10436165 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.

    Mann MJ, Gibbons GH, Hutchinson H, Poston RS, Hoyt EG, Robbins RC, Dzau VJ.

    Proc Natl Acad Sci U S A. 1999 May 25;96(11):6411-6.PMID: 10339601 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.

    Pollman MJ, Naumovski L, Gibbons GH.

    Circulation. 1999 Apr 20;99(15):2019-26.PMID: 10209007 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Regression of atherosclerosis: role of nitric oxide and apoptosis.

    Wang BY, Ho HK, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH, Tsao PS, Cooke JP.

    Circulation. 1999 Mar 9;99(9):1236-41.PMID: 10069793 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Endothelial cell apoptosis in capillary network remodeling.

    Pollman MJ, Naumovski L, Gibbons GH.

    J Cell Physiol. 1999 Mar;178(3):359-70.PMID: 9989782 [PubMed - indexed for MEDLINE]Related articles

    31.

    Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype.

    Pollman MJ, Hall JL, Gibbons GH.

    Circ Res. 1999 Jan 8-22;84(1):113-21.PMID: 9915780 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    The pathophysiology of hypertension: the importance of angiotensin II in cardiovascular remodeling.

    Gibbons GH.

    Am J Hypertens. 1998 Nov;11(11 Pt 2):177S-181S. Review.PMID: 9833876 [PubMed - indexed for MEDLINE]Related articles

    33.

    Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study.

    Yamada T, Akishita M, Pollman MJ, Gibbons GH, Dzau VJ, Horiuchi M.

    Life Sci. 1998;63(19):PL289-95.PMID: 9806232 [PubMed - indexed for MEDLINE]Related articles

    34.

    An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.

    Tomita N, Horiuchi M, Tomita S, Gibbons GH, Kim JY, Baran D, Dzau VJ.

    Am J Physiol. 1998 Aug;275(2 Pt 2):F278-84.PMID: 9691019 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    The working group report on science-based categories for abstracts: submitted to the annual scientific sessions. American Heart Association.

    Bonow RO, Mensah GA, Bettmann MA, Gibbons GH, Grant AO, Jalife J, Robertson RM.

    Circ Res. 1998 Apr 20;82(7):832-5. No abstract available. PMID: 9562444 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The Working Group report on Science-Based Categories for Abstracts: Submitted to the annual scientific sessions. American Heart Association.

    Bonow RO, Mensah GA, Bettmann MA, Gibbons GH, Grant AO, Jalife J, Robertson RM.

    Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):673-6. No abstract available. PMID: 9555875 [PubMed - indexed for MEDLINE]Related articles

    37.

    The Working Group report on Science-Based Categories for Abstracts: submitted to the annual scientific sessions. The Committee on Scientific Sessions Program (CSSP), American Heart Association.

    Bonow RO, Mensah GA, Bettmann MA, Gibbons GH, Grant AO, Jalife J, Robertson RM.

    Stroke. 1998 Apr;29(4):881-4. No abstract available. PMID: 9550530 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    The Working Group report of Science-Based Categories for abstracts submitted to the annual Scientific Sessions. The Committee on Scientific Sessions Program (CSSP), American Heart Association.

    Bonow RO, Mensah GA, Bettmann MA, Gibbons GH, Grant AO, Jalife J, Robertson RM.

    Hypertension. 1998 Apr;31(4):1042-5. No abstract available. PMID: 9535433 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.

    Morishita R, Gibbons GH, Horiuchi M, Kaneda Y, Ogihara T, Dzau VJ.

    Biochem Biophys Res Commun. 1998 Feb 13;243(2):361-7.PMID: 9480814 [PubMed - indexed for MEDLINE]Related articles

    40.

    Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease.

    Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH.

    Nat Med. 1998 Feb;4(2):222-7.PMID: 9461197 [PubMed - indexed for MEDLINE]Related articles

    42.

    Future horizons in cardiovascular molecular therapeutics.

    Dzau VJ, Gibbons GH, Mann M, Braun-Dullaeus R.

    Am J Cardiol. 1997 Nov 6;80(9A):33I-39I. Review.PMID: 9375940 [PubMed - indexed for MEDLINE]Related articles

    43.

    Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer.

    Morishita R, Gibbons GH, Horiuchi M, Nakajima M, Ellison KE, Lee W, Kaneda Y, Ogihara T, Dzau VJ.

    J Cardiovasc Pharmacol Ther. 1997 Jul;2(3):213-222.PMID: 10684460 [PubMed - as supplied by publisher]Related articles

    44.

    DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.

    Mann MJ, Morishita R, Gibbons GH, von der Leyen HE, Dzau VJ.

    Mol Cell Biochem. 1997 Jul;172(1-2):3-12.PMID: 9278227 [PubMed - indexed for MEDLINE]Related articles

    45.

    Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts.

    Mann MJ, Gibbons GH, Tsao PS, von der Leyen HE, Cooke JP, Buitrago R, Kernoff R, Dzau VJ.

    J Clin Invest. 1997 Mar 15;99(6):1295-301.PMID: 9077539 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Endothelial function as a determinant of vascular function and structure: a new therapeutic target.

    Gibbons GH.

    Am J Cardiol. 1997 Mar 6;79(5A):3-8. Review.PMID: 9127614 [PubMed - indexed for MEDLINE]Related articles

    47.

    Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance.

    Gibbons GH.

    Drugs. 1997;54 Suppl 5:1-11. Review.PMID: 9429840 [PubMed - indexed for MEDLINE]Related articles

    48.

    Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.

    Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ.

    Circulation. 1996 Dec 1;94(11):2756-67.PMID: 8941100 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II.

    Pollman MJ, Yamada T, Horiuchi M, Gibbons GH.

    Circ Res. 1996 Oct;79(4):748-56.PMID: 8831498 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Fusigenic liposome-mediated DNA transfer into cardiac myocytes.

    Ellison KE, Bishopric NH, Webster KA, Morishita R, Gibbons GH, Kaneda Y, Sato B, Dzau VJ.

    J Mol Cell Cardiol. 1996 Jul;28(7):1385-99.PMID: 8841927 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...